The global peripheral stent implants market is on track to experience substantial
growth, with forecasts indicating a remarkable expansion from an estimated US$3.9
billion in 2024 to a projected US$7.1 billion by 2031. This growth trajectory reflects a
nearly doubling of market size over the forecast period, exhibiting an impressive
compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.
View Market Insights:
https://www.fairfieldmarketresearch.com/report/peripheral-stentimplants-market
Quick Report Digest
The market for peripheral stent implants has witnessed consistent growth between
2019 and 2023, primarily driven by an increase in cases of peripheral artery disease
(PAD) and a growing preference for minimally invasive procedures. Technological
advancements, an ageing population, and the rise in lifestyle diseases such as
diabetes and obesity further contribute to market expansion.
Key Growth Determinants
1. Technological Advancements: Continuous innovation in stent design, materials,
and coatings has significantly enhanced the efficacy and safety of peripheral stent
implants. Advancements such as drug-eluting stents, bioresorbable stents, and
improved delivery systems have widened the application spectrum and improved
patient outcomes.
2. Ageing Population and Prevalence of Chronic Diseases: The increasing
prevalence of PAD and other vascular conditions, coupled with a growing ageing
population globally, fuels demand for peripheral stent implants. As the elderly
population grows, so does the incidence of conditions requiring vascular
interventions, thereby boosting the adoption of stent implants for peripheral artery
revascularisation.
3. Minimally Invasive Procedures: The shift towards minimally invasive procedures
has led to a surge in demand for peripheral stent implants. Patients and clinicians
alike prefer these procedures due to reduced trauma, shorter recovery times, and
lower healthcare costs compared to traditional open surgeries.
Major Growth Barriers
1. Regulatory Challenges: Stringent regulatory approval processes, particularly in
regions like the US and Europe, pose a significant barrier to market growth. Complex
regulatory requirements increase the time and cost associated with bringing new
peripheral stent products to market, thereby limiting innovation and expansion
opportunities for manufacturers.
2. High Costs and Reimbursement Issues: The high initial costs associated with
peripheral stent implants, including device procurement and procedural expenses,
can deter healthcare facilities from adopting these technologies. Additionally,
reimbursement issues and inadequate coverage by insurance providers in certain
markets create financial barriers for patients seeking peripheral artery
revascularisation.
3. Competition from Alternative Treatments: The peripheral stent implants market
faces competition from alternative treatment modalities such as balloon angioplasty,
atherectomy, and bypass surgery. These alternatives may be preferred in certain
clinical scenarios or by clinicians with specific expertise, leading to market
fragmentation and limiting the growth potential of peripheral stent implants.
Key Trends and Opportunities
1. Personalised Medicine and Precision Healthcare: Recent advancements in
medical imaging technologies and computational modelling have enabled the
customisation of peripheral stent implants to individual patient anatomies and
pathologies. This trend towards personalised medicine allows for the development of
patient-specific treatment plans, optimising stent selection, sizing, and placement for
improved outcomes.
2. Shift Towards Bioresorbable Stents: There is a growing interest in
bioresorbable stents as an alternative to traditional metallic stents in peripheral artery
revascularisation procedures. Bioresorbable stents gradually degrade and are
absorbed by the body over time, potentially reducing the long-term risk of
complications such as restenosis and thrombosis.
3. Emerging Markets Expansion: Significant untapped potential exists for
peripheral stent implants in emerging markets, particularly in regions with rapidly
growing healthcare infrastructure and increasing prevalence of cardiovascular
diseases.
How Does the Regulatory Scenario Shape this Industry?
The regulatory environment plays a vital role in the peripheral stent implants market,
impacting product approvals, reimbursements, and technological advancements.
Stringent regulations ensure patient safety but can also pose challenges for
innovation and market expansion.
Fairfield’s Ranking Board
Top Segments
1. Drug Eluting Stents (DES): DES are currently one of the top-performing
segments in the market due to their excellent safety and performance profile. Their
ability to release medication to prevent restenosis makes them highly preferred,
especially in reducing the need for repeat procedures and improving patient
outcomes.
2. Bare Metal Stents (BMS): Despite facing competition from DES, BMS remain
significant due to their cost efficiency. They are preferred in certain clinical scenarios
where the risk of long-term antiplatelet therapy is a concern or in resource-limited
settings.
3. Covered Stents: Covered stents have gained traction, particularly in the
treatment of complex peripheral artery lesions. Their unique design effectively seals
off defects in diseased vessels, reducing the risk of complications and improving
patient outcomes.
Regional Frontrunners
1. North America: Dominates the market due to high PAD prevalence, advanced
healthcare systems, and strong adoption of minimally invasive procedures.
2. Asia Pacific and Europe: Witnessing significant growth driven by increasing
healthcare spending, improving medical infrastructure, and an ageing population.
Fairfield’s Competitive Landscape Analysis
Intense rivalry among key players characterises the competition landscape of the
peripheral stent implants market. Leading companies employ various growth
strategies, including product innovation, strategic collaborations, partnerships,
acquisitions, and geographic expansion, to gain a competitive edge.
Leaders in Global Peripheral Stent Implants Space
Key players include Abbott Laboratories, Boston Scientific Corporation, Medtronic
Plc., Terumo Corporation, and Cook Medical, among others.
Significant Company Developments
Recent developments include product launches aimed at addressing unmet clinical
needs, strategic distribution agreements to expand market reach, and advancements
in stent technology to improve patient outcomes.
Global Peripheral Stent Implants Market Segmentation:

By Product: Bare Metal Stents (BMS), Covered Stents, Drug Eluting Stents
(DES)

By Artery: Carotid Artery Stents, Fem-Pop Artery Stents, Iliac Artery Stents,
Infrapop Artery Stents

By End User: Hospitals, Ambulatory Surgical Centres/Outpatients

By Region: North America, Europe, Asia Pacific, Latin America, Middle East
& Africa